| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.24 | 0.09 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |